Education
About Us
Working with TipRanks
Follow Us
Hisamitsu Pharmaceutical Co (JP:4530)
:4530
RESEARCH TOOLSreports
4530 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥3,629.00 - ¥4,735.00
Previous CloseN/A
Volume86.40K
Average Volume (3M)111.80K
Market Cap
¥311.48B
Enterprise Value¥350.68B
Total Cash (Recent Filing)¥116.64B
Total Debt (Recent Filing)¥2.93B
Price to Earnings (P/E)14.4
Beta0.23
Next Earnings
Jul 10, 2025EPS Estimate
68.8Last Dividend Ex-Date
Feb 27, 2025Dividend Yield2.01%
Share Statistics
EPS (TTM)295.76
Shares Outstanding75,164,894
10 Day Avg. Volume132,840
30 Day Avg. Volume111,803
Financial Highlights & Ratios
PEG Ratio1.06
Price to Book (P/B)1.18
Price to Sales (P/S)0.00
P/FCF Ratio62.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Hisamitsu Pharmaceutical Co News
PremiumCompany Announcements
Hisamitsu Pharmaceutical Announces New Executive Appointments
PremiumCompany Announcements
Hisamitsu Pharmaceutical Announces Board of Directors Candidates
PremiumCompany Announcements
Hisamitsu Pharmaceutical Co. Reports Q2 GrowthPremiumPre-Earnings
Is HTSUF a Buy, Before Earnings?
PremiumCompany Announcements
Hisamitsu Pharma Reports Strong Q1 ResultsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.44%
Mutual Funds
― Other Institutional Investors
93.70% Public Companies and
Individual Investors
4530 FAQ
What was Hisamitsu Pharmaceutical Co ’s price range in the past 12 months?
Hisamitsu Pharmaceutical Co lowest stock price was ¥3629.00 and its highest was ¥4735.00 in the past 12 months.
What is Hisamitsu Pharmaceutical Co ’s market cap?
Hisamitsu Pharmaceutical Co ’s market cap is ¥311.48B.
When is Hisamitsu Pharmaceutical Co ’s upcoming earnings report date?
Hisamitsu Pharmaceutical Co ’s upcoming earnings report date is Jul 10, 2025 which is in 19 days.
How were Hisamitsu Pharmaceutical Co ’s earnings last quarter?
Hisamitsu Pharmaceutical Co released its earnings results on Jan 09, 2025. The company reported ¥62.31 earnings per share for the quarter, beating the consensus estimate of N/A by ¥62.31.
Is Hisamitsu Pharmaceutical Co overvalued?
According to Wall Street analysts Hisamitsu Pharmaceutical Co ’s price is currently Overvalued.
Does Hisamitsu Pharmaceutical Co pay dividends?
Hisamitsu Pharmaceutical Co pays a Semiannually dividend of ¥43 which represents an annual dividend yield of 2.01%. See more information on Hisamitsu Pharmaceutical Co dividends here
What is Hisamitsu Pharmaceutical Co ’s EPS estimate?
Hisamitsu Pharmaceutical Co ’s EPS estimate is 68.8.
How many shares outstanding does Hisamitsu Pharmaceutical Co have?
Hisamitsu Pharmaceutical Co has 75,164,894 shares outstanding.
What happened to Hisamitsu Pharmaceutical Co ’s price movement after its last earnings report?
Hisamitsu Pharmaceutical Co reported an EPS of ¥62.31 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.173%.
Which hedge fund is a major shareholder of Hisamitsu Pharmaceutical Co ?
Currently, no hedge funds are holding shares in JP:4530
Company Description
Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company that specializes in the development, production, and marketing of pharmaceutical products and medical devices. The company is renowned for its transdermal patch technology and is a leader in the pain relief and anti-inflammatory sectors. Its flagship products include the Salonpas line of pain relief patches, which are widely distributed both domestically and internationally.
Technical Analysis
Nippon Shinyaku Co., Ltd.
―
SAWAI GROUP HOLDINGS Co., Ltd.
―
Sumitomo Dainippon Pharma Co
―
Tsumura & Co
―
Torii Pharmaceutical Co
―